JP2023510778A5 - - Google Patents

Info

Publication number
JP2023510778A5
JP2023510778A5 JP2022542118A JP2022542118A JP2023510778A5 JP 2023510778 A5 JP2023510778 A5 JP 2023510778A5 JP 2022542118 A JP2022542118 A JP 2022542118A JP 2022542118 A JP2022542118 A JP 2022542118A JP 2023510778 A5 JP2023510778 A5 JP 2023510778A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl groups
optionally
membered
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022542118A
Other languages
English (en)
Japanese (ja)
Other versions
JP7791822B2 (ja
JP2023510778A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/012282 external-priority patent/WO2021141969A1/en
Publication of JP2023510778A publication Critical patent/JP2023510778A/ja
Publication of JP2023510778A5 publication Critical patent/JP2023510778A5/ja
Priority to JP2025160231A priority Critical patent/JP2026016394A/ja
Application granted granted Critical
Publication of JP7791822B2 publication Critical patent/JP7791822B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022542118A 2020-01-09 2021-01-06 ナノマテリアル Active JP7791822B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025160231A JP2026016394A (ja) 2020-01-09 2025-09-26 ナノマテリアル

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062958876P 2020-01-09 2020-01-09
US62/958,876 2020-01-09
PCT/US2021/012282 WO2021141969A1 (en) 2020-01-09 2021-01-06 Nanomaterials

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025160231A Division JP2026016394A (ja) 2020-01-09 2025-09-26 ナノマテリアル

Publications (3)

Publication Number Publication Date
JP2023510778A JP2023510778A (ja) 2023-03-15
JP2023510778A5 true JP2023510778A5 (cg-RX-API-DMAC7.html) 2024-01-17
JP7791822B2 JP7791822B2 (ja) 2025-12-24

Family

ID=76788721

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022542118A Active JP7791822B2 (ja) 2020-01-09 2021-01-06 ナノマテリアル
JP2025160231A Pending JP2026016394A (ja) 2020-01-09 2025-09-26 ナノマテリアル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025160231A Pending JP2026016394A (ja) 2020-01-09 2025-09-26 ナノマテリアル

Country Status (11)

Country Link
US (2) US12435035B2 (cg-RX-API-DMAC7.html)
EP (1) EP4103542A4 (cg-RX-API-DMAC7.html)
JP (2) JP7791822B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220123536A (cg-RX-API-DMAC7.html)
CN (2) CN115175894B (cg-RX-API-DMAC7.html)
AU (1) AU2021205837A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022013599A2 (cg-RX-API-DMAC7.html)
CA (1) CA3163161A1 (cg-RX-API-DMAC7.html)
IL (1) IL294318A (cg-RX-API-DMAC7.html)
MX (1) MX2022008455A (cg-RX-API-DMAC7.html)
WO (1) WO2021141969A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7600208B2 (ja) 2019-07-29 2024-12-16 ジョージア テック リサーチ コーポレイション 拘束された脂質を含むナノ材料およびその使用
CN115175894B (zh) 2020-01-09 2024-09-06 盖德治疗有限责任公司 纳米材料
JP2023534267A (ja) 2020-07-15 2023-08-08 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド ろ材を再生し、煙道ガスを洗浄する方法
WO2022060871A1 (en) 2020-09-15 2022-03-24 Verve Therapeutics, Inc. Lipid formulations for gene editing
MX2023004371A (es) 2020-10-14 2023-07-26 George Mason Res Foundation Inc Lípidos ionizables, y métodos de fabricación y uso de los mismos.
JP2024508347A (ja) * 2020-12-21 2024-02-27 ビーム セラピューティクス インク. エステル結合アセタールを含むナノ材料
CN116761888A (zh) 2021-01-20 2023-09-15 比姆医疗股份有限公司 纳米材料
EP4281080A4 (en) * 2021-01-20 2025-09-24 Beam Therapeutics Inc NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
WO2022168884A1 (ja) * 2021-02-04 2022-08-11 塩野義製薬株式会社 カチオン性脂質
JP7883580B2 (ja) * 2021-10-08 2026-07-01 スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド 脂質化合物及び脂質ナノ粒子組成物
JP2025504430A (ja) * 2022-01-17 2025-02-12 サノフイ 脂質化合物及びその使用
CN117105737B (zh) * 2022-05-16 2026-05-01 四川大学 一种基于烯烃氢羧基化合成烷基羧酸类化合物的方法
WO2023230601A1 (en) 2022-05-27 2023-11-30 Beam Therapeutics Inc. Identification of nanoparticles for preferential tissue or cell targeting
EP4540222A1 (en) 2022-07-20 2025-04-23 Beam Therapeutics Inc. Nanomaterials comprising triols
WO2024199282A1 (zh) * 2023-03-28 2024-10-03 苏州艾博生物科技有限公司 脂质化合物和脂质纳米颗粒组合物
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
WO2025038864A1 (en) * 2023-08-16 2025-02-20 Beam Therapeutics Inc. Ionizable lipids with linear head groups
CN119490447A (zh) * 2023-08-17 2025-02-21 苏州星核迪赛生物技术有限公司 药物递送材料及其应用
WO2025166314A1 (en) * 2024-02-02 2025-08-07 Tessera Therapeutics, Inc. Ex vivo delivery of lipid nanoparticles for delivery of gene modifying systems to t cells
WO2025212851A2 (en) 2024-04-03 2025-10-09 Orbital Therapeutics, Inc. mRNA COMPOSITIONS AND USES THEREOF IN VARICELLA ZOSTER VIRUS VACCINES
WO2025259931A1 (en) 2024-06-14 2025-12-18 Orbital Therapeutics, Inc. Compositions and methods for rna circularization
WO2026006203A2 (en) 2024-06-24 2026-01-02 Orbital Therapeutics, Inc. Compositions and methods for making circular rna
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026006687A1 (en) 2024-06-28 2026-01-02 Orbital Therapeutics, Inc. Circular rna compositions and uses thereof for diseases caused by varicella-zoster virus

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL257307A (cg-RX-API-DMAC7.html) 1959-10-28
US3686238A (en) 1970-01-19 1972-08-22 Syntex Corp Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
EP1021549A2 (en) 1997-09-19 2000-07-26 Sequitur, Inc. SENSE mRNA THERAPY
EP1164125A4 (en) 1999-11-08 2005-05-04 Daicel Chem ADAMANTANE DERIVATIVES AND PROCESS FOR PREPARING
CN100523215C (zh) 2000-12-01 2009-08-05 马普科技促进协会 介导rna干涉的小rna分子
WO2003101952A2 (en) 2002-05-31 2003-12-11 The Regents Of The University Of California Polyamine-mediated transfection
JP2005181734A (ja) 2003-12-19 2005-07-07 Fuji Photo Film Co Ltd 画像記録材料
DE102007029471A1 (de) 2007-06-20 2008-12-24 Novosom Ag Neue fakultativ kationische Sterole
EP2279254B1 (en) 2008-04-15 2017-07-05 Protiva Biotherapeutics Inc. Novel lipid formulations for nucleic acid delivery
EP4481047A3 (en) 2010-06-03 2025-04-16 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
US9512073B2 (en) 2011-10-27 2016-12-06 Massachusetts Institute Of Technology Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
DE21212055T1 (de) 2011-12-07 2022-08-04 Alnylam Pharmaceuticals, Inc. Biologisch abbaubare lipide zur freisetzung von wirkstoffen
ES2887254T3 (es) 2013-03-08 2021-12-22 Novartis Ag Lípidos y composiciones lipídicas para el suministro de agentes activos
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
US10059655B2 (en) 2013-12-19 2018-08-28 Novartis Ag Lipids and lipid compositions for the delivery of active agents
US10426737B2 (en) 2013-12-19 2019-10-01 Novartis Ag Lipids and lipid compositions for the delivery of active agents
ES2969956T3 (es) 2014-09-05 2024-05-23 Novartis Ag Lípidos y composiciones lipídicas para el suministro de agentes activos
WO2016187531A1 (en) 2015-05-21 2016-11-24 Ohio State Innovation Foundation Benzene-1,3,5-tricarboxamide derivatives and uses thereof
HRP20220156T1 (hr) 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
CN108368028B (zh) * 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
ES3030658T3 (en) 2016-03-30 2025-07-01 Intellia Therapeutics Inc Lipid nanoparticle formulations for crispr/cas components
EP4303228B1 (en) 2016-07-11 2026-05-27 OPKO Biologics Ltd. Long-acting coagulation factor vii and methods of producing same
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
RS63953B1 (sr) * 2017-03-15 2023-02-28 Modernatx Inc Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava
BR112019025104A2 (pt) 2017-05-30 2020-06-23 Glaxosmithkline Biologicals S.A. Método de fabricar um sistema de entrega não viral, sistema de entrega não viral, e, composição
KR102710962B1 (ko) 2017-07-04 2024-09-27 주식회사 인투셀 절단성 링커를 포함하는 화합물 및 이들의 용도
JP7449231B2 (ja) 2017-10-30 2024-03-13 ジョージア テック リサーチ コーポレーション 組織送達用材料の多重化解析
US11622942B2 (en) 2017-11-14 2023-04-11 Ohio State Innovation Foundation Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereof
EP3727362A4 (en) 2017-12-19 2021-10-06 PureTech LYT, Inc. MYCOPHENOLIC ACID LIPID PRODRUGS AND THEIR USES
CN111542338B (zh) 2017-12-27 2024-06-18 武田药品工业株式会社 含核酸脂质纳米粒子及其用途
CN112955099B (zh) 2018-07-27 2024-04-26 雷森斯医疗有限公司 医疗冷却装置和使用其的冷却方法
US20210300962A1 (en) 2018-08-02 2021-09-30 Puretech Lyt, Inc. Lipid prodrugs of pregnane neurosteroids and uses thereof
JP7436990B2 (ja) 2018-08-10 2024-02-22 国立大学法人京都大学 カチオン性脂質を用いた心筋細胞へのトランスフェクション方法
MX2021003455A (es) 2018-10-02 2021-09-21 Intellia Therapeutics Inc Lípidos con amina ionizables.
CN119285480A (zh) 2018-12-05 2025-01-10 英特利亚治疗股份有限公司 改性的胺脂质
EP3911302B1 (en) 2019-01-17 2025-09-10 Georgia Tech Research Corporation Drug delivery systems containing oxidized cholesterols
ES3025233T3 (en) 2019-01-24 2025-06-06 Agfa Nv Radiation curable inkjet inks for interior decoration
EP3924479A4 (en) 2019-02-13 2023-01-25 Beam Therapeutics, Inc. ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING THEM TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE
AU2020228662A1 (en) 2019-02-28 2021-09-09 Monash University Lipid prodrugs of JAK inhibitors and uses thereof
WO2020176856A1 (en) 2019-02-28 2020-09-03 Puretech Lyt, Inc. Lipid prodrugs of glucocorticoids and uses thereof
WO2020176868A1 (en) 2019-02-28 2020-09-03 Puretech Lyt, Inc. Lipid prodrugs of btk inhibitors and uses thereof
WO2020219876A1 (en) 2019-04-25 2020-10-29 Intellia Therapeutics, Inc. Ionizable amine lipids and lipid nanoparticles
US20220233459A1 (en) 2019-06-05 2022-07-28 Guide Therapeutics, Inc. Analysis of materials for tissue delivery
CA3143865A1 (en) 2019-06-07 2020-12-10 Fujifilm Corporation Lipid composition
JP7600208B2 (ja) 2019-07-29 2024-12-16 ジョージア テック リサーチ コーポレイション 拘束された脂質を含むナノ材料およびその使用
EP4004207A4 (en) 2019-07-29 2023-08-23 Georgia Tech Research Corporation OLIGONUCLEOTIDE ANTAGONISTS FOR RNA-GUIDED GENO EDITING
JP2022552724A (ja) 2019-10-21 2022-12-19 フラスクワークス, エルエルシー 細胞培養のためのシステムおよび方法
JP7699128B2 (ja) 2019-12-06 2025-06-26 ガイド セラピューティクス,エルエルシー ナノマテリアル
CN115175894B (zh) 2020-01-09 2024-09-06 盖德治疗有限责任公司 纳米材料
JP2024505327A (ja) 2020-12-21 2024-02-06 ビーム セラピューティクス インク. 炭酸塩を含むナノ材料
JP2024508347A (ja) 2020-12-21 2024-02-27 ビーム セラピューティクス インク. エステル結合アセタールを含むナノ材料
EP4262817A4 (en) 2020-12-21 2025-03-12 Beam Therapeutics Inc. NANOMATERIALS WITH ACETALS
EP4281080A4 (en) 2021-01-20 2025-09-24 Beam Therapeutics Inc NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
CA3203741A1 (en) 2021-01-20 2022-07-28 Beam Therapeutics Inc. Nanomaterials comprising an ionizable lipid
CN116761888A (zh) 2021-01-20 2023-09-15 比姆医疗股份有限公司 纳米材料
AU2022210299A1 (en) 2021-01-20 2023-06-29 Beam Therapeutics Inc. Ionizable lipids for nanomaterials
WO2022251665A1 (en) 2021-05-28 2022-12-01 Renagade Therapeutics Management Inc. Lipid nanoparticles and methods of use thereof
JP7883580B2 (ja) 2021-10-08 2026-07-01 スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド 脂質化合物及び脂質ナノ粒子組成物
WO2023121971A1 (en) 2021-12-20 2023-06-29 Beam Therapeutics Inc. Nanomaterials comprising tetravalent lipid compounds
WO2023121964A1 (en) 2021-12-20 2023-06-29 Beam Therapeutics Inc. Nanomaterials comprising disulfides
WO2023121965A1 (en) 2021-12-20 2023-06-29 Beam Therapeutics Inc. Nanomaterial comprising diamines
WO2023121970A1 (en) 2021-12-20 2023-06-29 Beam Therapeutics Inc. Ionizable amine and ester lipids and lipid nanoparticles
CA3241488A1 (en) 2021-12-20 2023-06-29 Beam Therapeutics Inc. Ionizable amine lipids and lipid nanoparticles
EP4540222A1 (en) 2022-07-20 2025-04-23 Beam Therapeutics Inc. Nanomaterials comprising triols

Similar Documents

Publication Publication Date Title
JP2023505316A5 (cg-RX-API-DMAC7.html)
JP2025181861A5 (cg-RX-API-DMAC7.html)
AU2023200568C1 (en) Novel lipids and compositions for the delivery of therapeutics
CA2767129C (en) Compositions and methods for silencing apolipoprotein b
CN104004018B (zh) 具有含氮脂环式骨架的单链核酸分子
CN111343994B (zh) 用于抑制血管生成素-样3 (ANGPTL3)的表达的RNAi剂和组合物以及使用方法
ES3017428T3 (en) Ionizable cationic lipids for lipid nanoparticles
AU2022268351A1 (en) Di-aliphatic substituted pegylated lipids
JP7748500B2 (ja) トリループを含む二本鎖核酸インヒビター分子
AU2008242583B2 (en) Glycoconjugates of RNA interference agents
CN109562188B (zh) 与三价糖缀合物连接的核酸
Nawrot et al. Chemical and structural diversity of siRNA molecules
JP6422961B2 (ja) 改善された高効率ナノ粒子型オリゴヌクレオチド構造体およびその製造方法
JP2019530656A (ja) 4’−リン酸アナログ及びそれを含むオリゴヌクレオチド
JP2022528840A5 (cg-RX-API-DMAC7.html)
RU2020135289A (ru) Применение ингибиторов fubp1 для лечения инфекции вирусом гепатита в
WO2019074110A1 (ja) 一本鎖核酸分子およびその製造方法
KR20220004675A (ko) 단축 센스 가닥을 갖는 이중 가닥 핵산 억제제 분자
KR20260042246A (ko) 다가 카고 함유 복합체 및 이의 용도
JP2024508780A5 (cg-RX-API-DMAC7.html)
JP2024509906A5 (cg-RX-API-DMAC7.html)
TWI871840B (zh) 合成4'-磷酸鹽類似物核苷酸亞磷醯胺之方法
RU2026104839A (ru) Мультивалентные комплексы, несущие полезную нагрузку, и их применение
RU2020118025A (ru) Нуклеиновая кислота, композиция и конъюгат, содержащие ее, а также способ их получения и применения
JP2025517341A5 (cg-RX-API-DMAC7.html)